Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
ProShares Nanotechnology ETF
(ARCA:TINY)
Intraday
$46.7177
0.7447
[1.62%]
Get Report
Watch
Perks
Buy
Compare Brokers
$46.7177
0.7447
[1.62%]
At close: Apr 26
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for ProShares Nanotechnology ETF (ARCA:TINY)
ProShares Nanotechnology ETF (ARCA: TINY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, March 06, 2024
ACM Research Predicted To Achieve Double-Digit Growth in 2025 Due to Expanding Chip Demand: Analyst
Anusuya Lahiri
-
Mar 6, 2024, 2:40PM
Wednesday, March 15, 2017
Harris & Harris Group Reports FY16 Increase In Net Assets/Share $0.53 vs $0.65 In Same Qtr. Last Year, Total Investment Income $1.792M vs $0.916M YoY
Benzinga
-
Mar 15, 2017, 4:59PM
Wednesday, January 18, 2017
Financial & Investment Management Group Reports 5.75% Stake In Harris & Harris Group
Benzinga
-
Jan 18, 2017, 10:45AM
Tuesday, December 20, 2016
Harris & Harris Shares to Resume Trade at 5 p.m. EST
Benzinga
-
Dec 20, 2016, 4:46PM
UPDATE: Harris & Harris Says Has Developed Proposal to Split Into Two Entities: 180 Degree Capital, HALE.life Corp
Benzinga
-
Dec 20, 2016, 4:32PM
Harris & Harris Group Announces a Proposed Strategic Restructuring
Benzinga
-
Dec 20, 2016, 4:30PM
Harris & Harris Shares Halted News Pending
Benzinga
-
Dec 20, 2016, 4:25PM
Monday, October 24, 2016
Harris & Harris Group Shares Tick Higher as Co. Announces Its Portfolio Co., Mersana Therapeutics, Has Received FDA Clearance of IND App for XMT-1522
Benzinga
-
Oct 24, 2016, 12:05PM
Tuesday, August 09, 2016
Harris & Harris Reports NAV Of $81.284M And $2.63 NAV/Share
Benzinga
-
Aug 9, 2016, 9:12AM
Thursday, June 30, 2016
Director Rendino Buys 34,053 Shares of Harris & Harris @$1.66/Share -Form 4
Benzinga
-
Jun 30, 2016, 11:42AM
Wednesday, June 01, 2016
Harris & Harris Group Issues Quarterly Update Letter to Shareholders
Benzinga
-
Jun 1, 2016, 9:11AM
Monday, January 11, 2016
Harris & Harris Group Portfolio Launches Lodo Therapeutics Corp.
Benzinga
-
Jan 11, 2016, 11:32AM
Monday, December 28, 2015
UPDATE: Harris & Harris Says Milestone Payment from BioVex Purchase Increases Total Gross Proceeds from Sale ~$12.8M
Benzinga
-
Dec 28, 2015, 12:30PM
Harris & Harris Reports Receipt of ~$2.1M Milestone Payment Related to Purchase of BioVes by Amgen
Benzinga
-
Dec 28, 2015, 12:29PM
Friday, October 02, 2015
Harris & Harris Group Reports Receipt of Milestone Payment From Acquisition of Molecular Imprints by Canon
Benzinga
-
Oct 2, 2015, 9:01AM
Monday, September 28, 2015
Top 4 NASDAQ Stocks In The Diversified Investments Industry With The Highest EPS Growth Forecast For Next 5 Years
Benzinga
-
Sep 28, 2015, 4:35AM
Friday, July 31, 2015
Harris & Harris Group Shares Volatile Over Last Few Mins, But Largely Unchanged Following News Co.'s Portfolio Unit, HZO, Reported Partnerships with Dell Motoroa
Benzinga
-
Jul 31, 2015, 11:09AM
Wednesday, July 01, 2015
Haris & Harris Group, AgBiome, Report Partnership To Fasten The Finding Of Next Generation Insect-Resistant Crops
Benzinga
-
Jul 1, 2015, 11:46AM
Monday, May 18, 2015
5 NASDAQ Financial Stocks With The Highest EPS Growth Forecast For Next 5 Years
Benzinga
-
May 18, 2015, 9:16AM
Tuesday, January 20, 2015
13G: The Financial Consulate Inc. Reports 4.9% Passive Stake In Harris & Harris Group
Benzinga
-
Jan 20, 2015, 11:00AM
Thursday, June 13, 2013
Harris & Harris Highlights Carl Zeiss' Planned Purchase of Xradia
Benzinga
-
Jun 13, 2013, 10:20AM
Thursday, March 21, 2013
Ascendiant Capital Maintains Buy on Harris & Harris Group, Inc., Raises PT to $4.50
Benzinga
-
Mar 21, 2013, 8:55AM
Monday, December 03, 2012
Harris & Harris Closes Financing for Over $10M
Benzinga
-
Dec 3, 2012, 11:28AM
Wednesday, November 14, 2012
UPDATE: Ascendiant Capital Markets Reiterates Buy Rating, Lowers PT on Harris & Harris Group
Benzinga
-
Nov 14, 2012, 8:46AM
Ascendiant Capital Markets Maintains Harris & Harris Group at Buy, Lowers PT from $4.50 to $4
Benzinga
-
Nov 14, 2012, 8:09AM
Thursday, September 06, 2012
UPDATE: Ascendiant Capital Markets Initiates Harris & Harris Group at Buy with $4.50 on Catalysts
Benzinga
-
Sep 6, 2012, 11:39AM
Benzinga's Top Initiations
Benzinga
-
Sep 6, 2012, 7:27AM
Aegis Capital Initiates Coverage on Harris & Harris Group at Buy, Announces PT of $4.50
Benzinga
-
Sep 6, 2012, 5:44AM
Wednesday, August 22, 2012
Harris & Harris Group Letter to Shareholders Posted on Website
Benzinga
-
Aug 22, 2012, 4:24PM
Tuesday, May 29, 2012
Harris & Harris Group Notes Ensemble Therapeutics and Genentech Drug Discovery Collaboration
Benzinga
-
May 29, 2012, 10:31AM
Wednesday, March 07, 2012
Harris & Harris Group Announces Its Investment in OpGen
Benzinga
-
Mar 7, 2012, 9:24AM
Monday, August 15, 2011
Harris & Harris Group Announces Investment in HzO, Inc.
Benzinga
-
Aug 15, 2011, 8:51AM
Tuesday, September 21, 2010
Laser Light Engines Secures $13 Million Series B Financing
Benzinga
-
Sep 21, 2010, 8:04AM
Saturday, August 21, 2010
Review of the San Francisco Money Show: Recommended Stocks
Benzinga
-
Aug 21, 2010, 12:47AM